Adpaxil
Brand Name: ADPAXIL®
Composition: Paclitaxel Injection IP
Strength: 300 mg / 50 ml
Manufacturer/Marketer: Adley
Product Description
Medical Info
ADPAXIL® is a prescription antineoplastic medication containing Paclitaxel (300 mg/50 ml), formulated as a concentrated solution for intravenous infusion following dilution. Classified as a taxane agent, it works by stabilizing cellular microtubules, halting cancer cell division, and triggering apoptosis. This potent chemotherapy drug is a cornerstone treatment for various malignancies, including advanced ovarian, breast, and non-small cell lung carcinomas, as well as AIDS-related Kaposi’s sarcoma. Due to risks of severe hypersensitivity and bone marrow suppression, ADPAXIL® must be administered exclusively in a clinical setting under an oncologist’s close supervision.
Storage & Safety
Precautions & Warnings
Reconstitute only with the prescribed quantity of clean drinking water. Shake well before each use. Complete the full course as prescribed. Discard any unused suspension after 7 days of reconstitution.
Storage
Store in a cool, dry place below 25°C. Protect from light and moisture. Refrigeration after reconstitution is preferred.
Status
Keep all medicines out of reach of children.
